EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prior immunity to Ureaplasma urealyticum protects against respiratory infection in immunosuppressed mice

Maha Y Al-Jabri iD, Robin Patel iD, Derek Fleming iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01763-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Maha Y Al-Jabri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Divisin of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Ureaplasma urealyticum, Ureaplasma Infections, Immunocompromised Host. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ureaplasma species can cause systemic infections in immunocompromised hosts, including lung transplant recipients. Here, we investigated the impact of prior exposure to Ureaplasma urealyticum on the risk of U. urealyticum and Ureaplasma parvum infection in mice subjected to an immunosuppression regimen similar to that administered to solid organ transplant recipients. Mice were immunized with three intramuscular injections of U. urealyticum , with control mice injected with adjuvant only. Following immunization, mice received tacrolimus, mycophenolate mofetil, and methylprednisolone, and then were challenged with U. urealyticum or U. parvum intraperitoneally and intratracheally over 6 days. Relative U. urealyticum antibody levels in plasma were assessed over time, and lungs were harvested at sacrifice for bacterial load quantification, assessed using a color-changing unit assay. U. urealyticum antibody levels were higher in immunized compared with control animals ( P < 0.0001), even when animals were immunosuppressed. U. urealyticum and U. parvum lung burden was reduced in immunized compared with control mice (~6 log 10 reduction for U. urealyticum and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ureaplasma urealyticumUreaplasma InfectionsImmunocompromised HostAnimalsMiceFemaleRespiratory Tract InfectionsLungImmunosuppression TherapyAntibodies, BacterialImmunosuppressive AgentsHumans

Stichwörter der Autor:innen

UreaplamsaUreaplasma-induced hyperammonemiaimmunizationlung transplantation

Substanzen

Antibodies, BacterialImmunosuppressive Agents

Autor:innen und Institutionen

  • Divisin of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Maha Y Al-Jabri, Robin Patel, Derek Fleming

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Al-Jabri, M. Y., Patel, R., & Fleming, D. (2025). Prior immunity to Ureaplasma urealyticum protects against respiratory infection in immunosuppressed mice. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01763-24

Vancouver

Al-Jabri MY, Patel R, Fleming D. Prior immunity to Ureaplasma urealyticum protects against respiratory infection in immunosuppressed mice. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01763-24

BibTeX
@article{AlJabri2025,
  author = {Al-Jabri, Maha Y and Patel, Robin and Fleming, Derek},
  title = {Prior immunity to Ureaplasma urealyticum protects against respiratory infection in immunosuppressed mice},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01763-24}
}
Kostenlos starten →